- $2.11bn
- $1.69bn
- $1.12bn
Novavax up; Shah Capital to vote against board, exec pay
U.S. STOCKS ON THE MOVE-Delta, Levi's, banks
U.S. STOCKS ON THE MOVE-Delta, GATX, Humana
Novavax up; Shah Capital to vote against board, exec pay
Shah Capital intends to vote against Novavax's board nominees, executive compensation
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM
U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Brief: Novavax Appoints Dr. Robert Walker As Executive Vice President And Head Of Research & Development
U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike
Novavax rises after naming internal medicine specialist as R&D head
Novavax surges after raising annual revenue forecast
Novavax raises revenue forecast on boost from vaccine deals; shares soar (updated)
U.S. STOCKS ON THE MOVE-Qnity, J.M. Smucker, Vistra
Novavax up after raising annual revenue forecast
Brief: Novavax Outlook 2026 Adjusted Total Revenue $230 Mln - $270 Mln
Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals
What to Watch in the Day Ahead - Thursday, February 26
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality
U.S. STOCKS ON THE MOVE-Moderna, Seagate, Western Digital